Adicet Bio Stock Probability of Future Stock Price Finishing Under 0.91
| ACET Stock | USD 0.91 0.05 5.21% |
Adicet |
Adicet Bio Target Price Odds to finish below 0.91
The tendency of Adicet Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 0.91 | 90 days | 0.91 | about 7.62 |
Based on a normal probability distribution, the odds of Adicet Bio to move below current price in 90 days from now is about 7.62 (This Adicet Bio probability density function shows the probability of Adicet Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Adicet Bio has a beta of 0.4. This suggests as returns on the market go up, Adicet Bio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Adicet Bio will be expected to be much smaller as well. Additionally Adicet Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Adicet Bio Price Density |
| Price |
Predictive Modules for Adicet Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Adicet Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adicet Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Adicet Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Adicet Bio is not an exception. The market had few large corrections towards the Adicet Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Adicet Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Adicet Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.5 | |
β | Beta against Dow Jones | 0.40 | |
σ | Overall volatility | 0.21 | |
Ir | Information ratio | -0.12 |
Adicet Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Adicet Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Adicet Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Adicet Bio generated a negative expected return over the last 90 days | |
| Adicet Bio has some characteristics of a very speculative penny stock | |
| Adicet Bio has high historical volatility and very poor performance | |
| Adicet Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (142.66 M) with profit before overhead, payroll, taxes, and interest of 24.99 M. | |
| Adicet Bio currently holds about 260.64 M in cash with (93.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 76.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from businesswire.com: Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in MetastaticAdvanced Clear Cell Renal Cell Carcinoma |
Adicet Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Adicet Stock often depends not only on the future outlook of the current and potential Adicet Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adicet Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 43 M | |
| Cash And Short Term Investments | 159.7 M |
Adicet Bio Technical Analysis
Adicet Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Adicet Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Adicet Bio. In general, you should focus on analyzing Adicet Stock price patterns and their correlations with different microeconomic environments and drivers.
Adicet Bio Predictive Forecast Models
Adicet Bio's time-series forecasting models is one of many Adicet Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Adicet Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Adicet Bio
Checking the ongoing alerts about Adicet Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Adicet Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Adicet Bio generated a negative expected return over the last 90 days | |
| Adicet Bio has some characteristics of a very speculative penny stock | |
| Adicet Bio has high historical volatility and very poor performance | |
| Adicet Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (142.66 M) with profit before overhead, payroll, taxes, and interest of 24.99 M. | |
| Adicet Bio currently holds about 260.64 M in cash with (93.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 76.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from businesswire.com: Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in MetastaticAdvanced Clear Cell Renal Cell Carcinoma |
Additional Tools for Adicet Stock Analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.